The Institute for International Research will be holding their 14th Annual Immunogenicity for Biotherapeutics event in Baltimore, USA on March 18-20, 2013 at the Mariott Inner Harbor.
IIR’s Immunogenicity for Biotherapeutics has 14 years of proven history for giving industry leaders the tools and expertise they need in order to best design their immunoassays, preclinical research pipelines and molecular de-risking strategies.
This year’s agenda brings together industry experts with proven results on how to bridge both ever-present challenges of assay design and de-risking strategies for the next generation of molecular design. If you attend the event, you can;
- Optimize your risk minimization strategies to cover the entire preclinical-to-clinical life cycle
- Create and capitalize on the most advanced transgenic animal models to get the best grasp on predicting immunogenicity
- Identify the must-have features of molecular design to minimize or eliminate epitopes
- Adapt your skills to the unique features of newly-developed varieties of biomolecules, including biosimilars, nanomedicines, bispecifics and antibody-drug conjugates
For more information please check event’s website from here.